查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1595247

兒科醫療市場：按類型、治療藥物、治療類型 - 2025-2030 年全球預測

Pediatric Health Market by Type (Acute Illness, Chronic Illness), Therapeutics (Allergy & Immunology, Cardiology, Gastroenterology), Treatment Type - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年兒科醫療市場規模為1,060.4億美元，預計2024年將達1,136.3億美元，複合年成長率為8.00%，2030年將達1818.3億美元。

兒科醫療保健市場被定義為專注於嬰幼兒、兒童和青少年的醫療保健、健康和整體健康的行業，涵蓋從診斷到治療解決方案的廣泛服務。該市場的促進因素是確保兒童從出生到青春期的健康，從而預防和管理急性和慢性疾病，促進全面發展。其應用範圍涵蓋醫院、小兒科診所、藥房和居家照護服務，最終用途擴展到公共醫療機構、私人醫療保健提供者和私人家庭護理。關鍵的成長要素包括基於人工智慧的診斷等技術進步、對兒科醫療問題的認知提高以及醫療保健支出的增加。兒童疾病盛行率的增加、人口規模的迅速擴大以及兒科醫療設備的創新也對這一成長做出了重大貢獻。透過投資遠端醫療以遠端存取兒科醫療保健並開發針對個人基因譜的個人化醫療，充分利用潛在的商機。限制包括監管障礙、高昂的研發成本以及需要嚴格的臨床試驗，這可能會延遲產品的上市。此外，市場碎片化和對新技術的抵制等挑戰也可能阻礙成長。創新領域包括開發用於即時健康監測的穿戴式技術以及增強電子健康記錄（EHR）系統以實現無縫資料整合。尋求發展的公司應該探索與高科技公司的合作，開發人工智慧驅動的醫療解決方案，並利用巨量資料分析來建立預測醫療模型。在整體預防醫學和個人化醫學趨勢的背景下，市場正在發生重大變化。透過應對當前的監管複雜性、在藥物開發中利用生物資訊學以及培養跨行業夥伴關係關係，公司可以佔據重要的市場佔有率並推動兒科醫療保健的未來成長。

主要市場統計
基準年[2023] 1060.4億美元
預測年份 [2024] 1136.3億美元
預測年份 [2030] 1818.3億美元
複合年成長率（%） 8.00%

市場動態：揭示快速發展的兒科醫療保健市場的關鍵市場洞察

供需的動態交互作用正在改變兒科醫療保健市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 患有常見兒童疾病的兒童數量不斷增加
    • 政府針對兒童免疫計畫的舉措
    • 兒童慢性病負擔增加
  • 市場限制因素
    • 新生兒及罕見兒科疾病藥物開發有限
  • 市場機會
    • 重視罕見疾病新藥和治療方法的研發與引進
    • 增加兒科藥物和疫苗開發的投資和可用性
  • 市場挑戰
    • 與藥物相關的併發症

波特五力：駕馭兒科醫療市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解兒科醫療保健市場的外部影響

外部宏觀環境因素在塑造兒科醫療市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解兒科醫療市場的競爭狀況

對兒科醫療保健市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣兒科醫療市場供應商的績效評估

FPNV定位矩陣是評估兒科醫療保健市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃兒科醫療保健市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，兒科醫療保健市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 大量兒童患有常見兒童疾病
      • 政府關於兒童免疫計劃的舉措
      • 兒童慢性病負擔日益加重
    • 抑制因素
      • 新生兒及兒童罕見疾病藥物開發有限
    • 機會
      • 專注於罕見疾病新藥、新治療方法的研發與引進
      • 增加對兒科藥品和疫苗研發和供應的投資
    • 任務
      • 藥物相關併發症
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章兒科醫療市場：依類型

  • 急性疾病
  • 慢性病

第7章 兒科醫療市場治療

  • 過敏和免疫學
  • 心臟病學
  • 胃腸病學
    • 制酸劑
    • 止瀉
    • 瀉藥
  • 感染疾病

第8章 依治療類型分類的兒科醫療市場

  • 症狀治療
    • 藥品
    • 疫苗
  • 自然的

第9章美洲兒科醫療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區兒科醫療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲兒科醫療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Allucent
  • AstraZeneca PLC
  • Boehringer Ingelheim International GmbH
  • Gilead Sciences, Inc.
  • GlaxoSmithKline PLC
  • GP Pharm, SA
  • Henin Lukinz Pvt. Ltd.
  • Janssen Global Services LLC
  • Medexus Pharmaceuticals, Inc.
  • Novartis AG
  • ORPHELIA Pharma
  • Pfizer Inc.
  • Procter & Gamble Company
  • Proveca Ltd.
  • Sanofi SA
Product Code: MRR-62667ADF93FE

The Pediatric Health Market was valued at USD 106.04 billion in 2023, expected to reach USD 113.63 billion in 2024, and is projected to grow at a CAGR of 8.00%, to USD 181.83 billion by 2030.

The pediatric health market, defined as the sector focusing on medical care, wellness, and the overall health of infants, children, and adolescents, encompasses a range of services from diagnostics to treatment solutions. This market is driven by the necessity to ensure child health from birth through adolescence, thereby preventing and managing acute and chronic conditions to foster holistic development. Its application spans hospitals, pediatric clinics, pharmacies, and home care services, with end-use extending into public health organizations, private healthcare providers, and individual family care. Key growth factors include technological advancements like AI-driven diagnostics, growing awareness of pediatric health issues, and increased healthcare expenditure. The increasing prevalence of pediatric diseases, the booming population size, and innovation in pediatric medical devices also contribute significantly to this growth. Potential opportunities can be harnessed by investing in telemedicine for remote child healthcare access and developing personalized medicine to cater to individual genetic profiles. Limitations include regulatory hurdles, high R&D costs, and the need for rigorous clinical trials which can delay product launches. Additionally, challenging factors such as market fragmentation and resistance to new technologies could hinder growth potential. Innovation areas include development in wearable technology for real-time health monitoring and enhancing electronic health record (EHR) systems for seamless data integration. Businesses keen on growth should explore collaborations with tech firms to create AI-powered medical solutions and leverage big data analysis for predictive health care models. The market is profoundly dynamic, with a trend towards holistic, preventive, and personalized care. By addressing current regulatory complexities, utilizing bioinformatics for drug development, and fostering cross-industry partnerships, firms can capture significant market share and drive future growth in pediatric healthcare.

KEY MARKET STATISTICS
Base Year [2023] USD 106.04 billion
Estimated Year [2024] USD 113.63 billion
Forecast Year [2030] USD 181.83 billion
CAGR (%) 8.00%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pediatric Health Market

The Pediatric Health Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Significant pediatric population suffering from common childhood Illnesses
    • Government initiatives for pediatric immunization programs
    • Rising burden of chronic pediatric diseases
  • Market Restraints
    • Limited development of drugs targeting neonates and rare pediatric diseases
  • Market Opportunities
    • Focus on R&D and introduction of novel drugs and new therapeutic developments on rare diseases
    • Increasing investment in pediatric drug & vaccine development and its availability
  • Market Challenges
    • Complications associated with drugs

Porter's Five Forces: A Strategic Tool for Navigating the Pediatric Health Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pediatric Health Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pediatric Health Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pediatric Health Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pediatric Health Market

A detailed market share analysis in the Pediatric Health Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pediatric Health Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pediatric Health Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pediatric Health Market

A strategic analysis of the Pediatric Health Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pediatric Health Market, highlighting leading vendors and their innovative profiles. These include Allucent, AstraZeneca PLC, Boehringer Ingelheim International GmbH, Gilead Sciences, Inc., GlaxoSmithKline PLC, GP Pharm, S.A., Henin Lukinz Pvt. Ltd., Janssen Global Services LLC, Medexus Pharmaceuticals, Inc., Novartis AG, ORPHELIA Pharma, Pfizer Inc., Procter & Gamble Company, Proveca Ltd., and Sanofi S.A..

Market Segmentation & Coverage

This research report categorizes the Pediatric Health Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Acute Illness and Chronic Illness.
  • Based on Therapeutics, market is studied across Allergy & Immunology, Cardiology, Gastroenterology, and Infectious Disease. The Gastroenterology is further studied across Antacids, Antidiarrheal, and Laxatives.
  • Based on Treatment Type, market is studied across Allopathic and Natural. The Allopathic is further studied across Drugs and Vaccines.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Significant pediatric population suffering from common childhood Illnesses
      • 5.1.1.2. Government initiatives for pediatric immunization programs
      • 5.1.1.3. Rising burden of chronic pediatric diseases
    • 5.1.2. Restraints
      • 5.1.2.1. Limited development of drugs targeting neonates and rare pediatric diseases
    • 5.1.3. Opportunities
      • 5.1.3.1. Focus on R&D and introduction of novel drugs and new therapeutic developments on rare diseases
      • 5.1.3.2. Increasing investment in pediatric drug & vaccine development and its availability
    • 5.1.4. Challenges
      • 5.1.4.1. Complications associated with drugs
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pediatric Health Market, by Type

  • 6.1. Introduction
  • 6.2. Acute Illness
  • 6.3. Chronic Illness

7. Pediatric Health Market, by Therapeutics

  • 7.1. Introduction
  • 7.2. Allergy & Immunology
  • 7.3. Cardiology
  • 7.4. Gastroenterology
    • 7.4.1. Antacids
    • 7.4.2. Antidiarrheal
    • 7.4.3. Laxatives
  • 7.5. Infectious Disease

8. Pediatric Health Market, by Treatment Type

  • 8.1. Introduction
  • 8.2. Allopathic
    • 8.2.1. Drugs
    • 8.2.2. Vaccines
  • 8.3. Natural

9. Americas Pediatric Health Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Pediatric Health Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Pediatric Health Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Allucent
  • 2. AstraZeneca PLC
  • 3. Boehringer Ingelheim International GmbH
  • 4. Gilead Sciences, Inc.
  • 5. GlaxoSmithKline PLC
  • 6. GP Pharm, S.A.
  • 7. Henin Lukinz Pvt. Ltd.
  • 8. Janssen Global Services LLC
  • 9. Medexus Pharmaceuticals, Inc.
  • 10. Novartis AG
  • 11. ORPHELIA Pharma
  • 12. Pfizer Inc.
  • 13. Procter & Gamble Company
  • 14. Proveca Ltd.
  • 15. Sanofi S.A.

LIST OF FIGURES

  • FIGURE 1. PEDIATRIC HEALTH MARKET RESEARCH PROCESS
  • FIGURE 2. PEDIATRIC HEALTH MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PEDIATRIC HEALTH MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. PEDIATRIC HEALTH MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. PEDIATRIC HEALTH MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PEDIATRIC HEALTH MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PEDIATRIC HEALTH MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PEDIATRIC HEALTH MARKET DYNAMICS
  • TABLE 7. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ACUTE ILLNESS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY CHRONIC ILLNESS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ALLERGY & IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ANTACIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ANTIDIARRHEAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY LAXATIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY NATURAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 234. PEDIATRIC HEALTH MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 235. PEDIATRIC HEALTH MARKET, FPNV POSITIONING MATRIX, 2023